Elevated levels of transforming growth factors beta 2 and beta 3 in lambdoid sutures from children with persistent plagiocephaly

Cleft Palate-Craniofacial Journal

Volumn 34, Issue 4, 1997, Pages 331-337

  Lin, Kant Y ^a,c   Nolen, Amber A ^b   Gampper, Thomas J ^b   Jane, John A ^b   Opperman, Lynne A ^a   Ogle, Roy C ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cranial development; Craniosynostosis; Growth factors; Lambdoid sutures; Positional deformation

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; BONE CELL; CELL GROWTH; CHILD; CONSERVATIVE TREATMENT; CRANIOFACIAL SYNOSTOSIS; FEMALE; GENE MUTATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; OSTEOBLAST; PATIENT POSITIONING; PRIORITY JOURNAL; SKULL MALFORMATION; SUDDEN INFANT DEATH SYNDROME;

CELL DIFFERENTIATION; CELL DIVISION; CHILD DEVELOPMENT; COLORING AGENTS; CRANIAL SUTURES; CRANIOSYNOSTOSES; CRANIOTOMY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; INFANT; MALE; MOTOR SKILLS; MUSCLE HYPOTONIA; OCCIPITAL BONE; PARIETAL BONE; PRESSURE; SUDDEN INFANT DEATH; SUPINE POSITION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030749699     PISSN: 10556656     EISSN: None     Source Type: Journal    
DOI: 10.1597/1545-1569(1997)034<0330:ELOTGF>2.3.CO;2     Document Type: Article

References (36)

1. ANDERSSON H. Craniosynostosis as a complication after operation for hydrocephalus. Acta Paediatr Scand 1966;55:192-196.
2. ARGENTA LC, DAVID LR, WILSON JA, BELL WO. An increase in infant cranial deformity with supine sleeping position J Craniofac Surg 1996;7:5-11.
3. BAER MJ. Patterns of growth of the skull as revealed by vital staining. Hum Biol 1954;26:80-126.
4. BECKER LE, HINTON D. Pathogenesis of craniosynostosis. Pediatr Neurosurg 1995;22:104-107.
5. CENTRELLA M, MASSAGUE J, CANALIS E. Human platelet-derived transforming growth factor-β stimulates parameters of bone growth in fetal rat calvaria. Endocrinology 1986;119 2306-2312.
6. COHEN MM JR. Sutural biology and the correlates of craniosynostosis. Am J Med Genet 1993;47:581-616.
7. ENLOW DH. Normal and abnormal patterns of craniofacial growth. In: Persing JA, Edgerton MT, Jane JA, eds. Scientific foundations and surgical treatment of craniosynostosis. Baltimore: Williams & Wilkins, 1989:83-86.
8. FRYBURG JS, HWANG V, LIN KY. Recurrent lambdoid synostosis within two families. Am J Med Genet 1995;58:262-266.
9. HUANG MH, GRUSS J, CLARREN S, et al. The differential diagnosis of postenor plagiocephaly: true lambdoid synostosis versus positional molding. Plast Reconstr Surg 1996;98:765-774.
10. JABS EW, LI X, SCOTT AF, et al. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast receptor 2. Nature Genet 1994;8:275-279.
11. JABS EW, MULLER U, LI X, et al. A mutation in the homeodomain of the human msx2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993;75.443-450.
12. KASPERK CH, WERGEDAL JE, MOHAN S, et al. Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. Growth Factors 1990;3:147-158.
13. KATTWINKEL J, BROOKS J, MYERBERG D. Positioning and SIDS Pediatrics 1992;89.1120-1126.
14. LIN KY, POLIN R, GAMPPER TJ, JANE JA. A modified surgical approach to posterior skull deformities. J Neurosurg (Submitted for publication).
15. MCCOMB JG. Treatment of functional lambdoid synostosis. Neurosurg Clin North Am 1991;2:665-672.
16. MOSS ML. Inhibition and stimulation of suturai fusion in the rat calvaria. Anat Rec 1960;136:457-467.
17. MUAKKASSA KF, HOFFMAN HJ, HINTON PR, et al. Lambdoid synostosis. J Neurosurg 1986,61:340-347.
18. MUENKE M, SCHELL U, HEHR A, et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet 1994;8: 269-274.
19. OPPERMAN LA, NOLEN AA, CASINGHINO S, et al. Tissue specific distribution and expression of TGF-β 1, 2 and 3 by rat calvaria: possible role in skull morphogenesis. Mol Biol Cell 1994a;5.465a.
20. OPPERMAN LA, NOLEN AA, OGLE RC. TGF-β1, TGF-β2 and TGF-β3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Min Res 1997;12:301-310.
21. OPPERMAN LA, PASSARELLI RW, MORGAN EP, et al. Tissue interactions with dura mater enable fetal cranial sutures to resist osseous obliteration in vitro. J Bone Min Res 1995;10:1978-1987.
22. OPPERMAN LA, PASSARELLI RW, NOLEN AA, et al. Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell Develop Biol 1996;32:627-632.
23. OPPERMAN LA, SHEEN R, PERSING JA, OGLE RC. In the absence of periosteum, transplanted fetal and neonatal rat coronal sutures resist osseous obliteration. J Craniofac Surg 1994b;5:327-332.
24. OPPERMAN LA, SWEENEY TM, PERSING JA, OGLE RC. Tissue interactions with dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dyn 1993;198:312-322.
25. PERSING JA. Occipital deformities. J Craniofac Surg 1996;7.4.
26. PERSING JA, BABLER WJ, JANE JA, DUCKWORTH PF. Experimental unilateral coronal synostosis in rabbits. Plast Reconstr Surg 1986a,77.369-377.
27. PERSING JA, NICHTER L, JANE JA, EDGERTON M. External cranial vault molding after craniofacial surgery. Ann Plast Surg 1986b;17:274-283.
28. REARDON W, WINTER RM, RUTLAND P, et al Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet 1994;8:98-103.
29. RIPLEY CE, POMATTO J, BEALS SP, et al. Treatment of positional plagiocephaly with dynamic orthotopic cranioplasty. J Craniofac Surg 1994;5: 150-154.
30. ROTH DA, LONGAKER MT, BREITBART AS, et al. The role of transforming growth factor beta-1 in rat cranial suture fusion. Proceedings of the 63rd Annual Scientific Meeting ASPRS-PSEF-ASMS, San Diego. California, September 1994:39-40.
31. SADOVE MA. Positional plagiocephaly. J Craniofac Surg 1996;7:3.
32. SMITH DW, TONDURY G. Origin of the calvaria and its sutures. Am J Dis Child 1978;132:662-666.
33. STEIN GS, LIAN JB. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblastic phenotype. Endocr Rev 1993,14:424-442.
34. TEN DYKE P, IWATA KK, GODDARD C, et al. Recombinant transforming growth factor type β3: biological activities and receptor-binding properties in isolated bone cells. Mol Cell Biol 1990;10:4473-4479.
35. TURK AE, MCCARTHY JG, THORNE CHM, WISOFF JH. The "back to sleep campaign" and deformational plagiocephaly: Is there cause for concern? J Craniofac Surg 1996;7:12-18.
36. WILKIE AOM, SLANEY SF, OLDRIDGE M, et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet 1995;9:165-172.